Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts. 1982

B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
May 1985, Lancet (London, England),
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
September 1985, Lancet (London, England),
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
August 1992, Transplantation proceedings,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
May 1988, The British journal of dermatology,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
February 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
June 1994, Kidney international,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
January 1995, American journal of nephrology,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
August 1983, Transplantation,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
May 1988, Medicina clinica,
B D Kahan, and C T Van Buren, and S N Lin, and Y Ono, and G Agostino, and S J LeGrue, and M Boileau, and W D Payne, and R H Kerman
August 1991, Clinical and experimental immunology,
Copied contents to your clipboard!